Search alternatives:
points decrease » point decrease (Expand Search), point increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
_ points » _ point (Expand Search), 5 point (Expand Search)
50 n » 50 ns (Expand Search), 50 ng (Expand Search), 50 _ (Expand Search)
points decrease » point decrease (Expand Search), point increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
_ points » _ point (Expand Search), 5 point (Expand Search)
50 n » 50 ns (Expand Search), 50 ng (Expand Search), 50 _ (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Proteasome activity was decreased in the <i>myc-rpt6-S119A</i> mutant.
Published 2017“…The mean ± SEM rate of Suc-LLVY-AMC cleavage is decreased in the <i>myc-rpt6-S119A</i> mutant compared to the WT and <i>myc-rpt6-S119D</i> strains. …”
-
8
-
9
-
10
-
11
-
12
-
13
nLTD decreases the molecular proximity between endogenous spine cofilin and F-actin
Published 2014“…Regardless of antibody combination we found that nLTD decreased the detection of cofilin-actin interaction (data shown in either <i>blue</i> or <i>yellow bars</i>). …”
-
14
-
15
-
16
Decreased oscillatory flow decreases <i>klf2a</i> expression.
Published 2009“…(G) <i>klf2a</i> expression decreases after 15-h lidocaine treatment (90%, <i>n</i> = 67). …”
-
17
-
18
-
19
-
20
Viability of microencapsulated FP ICCs decreased with time post-transplantation.
Published 2013“…<p>A) Fluorescent images of encapsulated FP ICCs stained with 6-CFDA for viable cells (green) and PI for non-viable cells (red) to assess viability at (A) pre-transplantation, (B) day 1, (C) day 3, (D) day 7, (E) day 14 and (F) day 21 post-transplantation. B) Viability decreased with time post-transplantation. Values are mean ± SEM (n = 100 microcapsules/mice for each time point); *p<0.05 viability for days 7 to 21 when compared to pre-transplantation control and days 1 and 3 post-transplantation; #p<0.05 viability for days 14 and 21 when compared to day 7 post-transplantation (one-way ANOVA with post-hoc Tukey-Kramer Multiple-Comparison test).…”